Azacitidine 63323-0771-39
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 16, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA207518
Need to source Azacitidine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Azacitidine | 100 mg/30mL |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Selected Package
63323-0771-39Selected1 VIAL, SINGLE-DOSE in 1 CARTON (63323-771-39) / 30 mL in 1 VIAL, SINGLE-DOSE